Respiratory pharmacotherapy in emergency and critical care medicine.
Successful pharmacologic management of most respiratory diseases is possible. All moderately to severely affected animals benefit from rest and supplemental oxygen. Careful identification of the underlying cause as well as an understanding of the pathophysiology behind various diseases is essential to successful patient outcome.
Rozanski
Elizabeth A
EA
Section of Critical Care, Department of Clinical Sciences, Tufts University, 200 Westboro Road, North Grafton, MA 01536, USA. Elizabeth.rozanski@tufts.edu
Rondeau
Mark P
MP
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000662:veterinary; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002371:Cat Diseases / Q000188:drug therapy*; D002415:Cats; D003422:Critical Care; D004232:Diuretics / Q000627:therapeutic use; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D004638:Emergency Treatment / Q000662:veterinary; D011014:Pneumonia / Q000188:drug therapy / Q000662:veterinary; D011654:Pulmonary Edema / Q000188:drug therapy / Q000662:veterinary; D011655:Pulmonary Embolism / Q000188:drug therapy / Q000662:veterinary; D012128:Respiratory Distress Syndrome / Q000188:drug therapy / Q000662:veterinary*
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D001993:Bronchodilator Agents; D004232:Diuretics